DiversifiedNSE · BSE

Syncom Formulations (India) Ltd.

SYNCOMF · ISIN INE312C01025

Share price

₹14.34▼ -0.90%

Market capitalisation

₹1348 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹1348 Cr

Current price

₹14.34

-0.90% today

52W high

₹21.25

52W low

₹10.21

Stock P/E

17.7

P/B ratio

3.49

02 · Per share & returns

EPS (TTM)

₹0.81

Book value

₹4.10

ROE

20.19%

ROA

9.36%

Dividend yield

0.00%

Beta

0.72

03 · Financials (TTM)

By the numbers

Revenue

₹489 Cr

-9.00% YoY

EBITDA

₹75.64 Cr

Net profit

₹76.44 Cr

+68.80% YoY

Profit margin

15.63%

Operating margin

14.42%

Total debt

₹1.47 Cr

Total cash

₹113 Cr

Debt / equity

0.00x

Current ratio

3.19x

Payout ratio

0.00%

04 · Analyst view

Target price

—

Upside

—

Consensus

NONE

Analysts

—

05 · Shareholding pattern

Who owns SYNCOMF?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol: SYNCOMF
Exchange: NSE · BSE
CIN: —
ISIN: INE312C01025
BSE code: 524470
Sector: Diversified
Industry: —
Face value: ₹1
Listing date: 17 Nov 2022
Employees: —
Headquarters: Indore, India
Website: www.syncomformulations.com

07 · About

What is Syncom Formulations (India) Ltd.?

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

08 · Common questions

Frequently asked

What is the CIN of Syncom Formulations (India) Ltd.?+

The Corporate Identity Number for Syncom Formulations (India) Ltd. is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Syncom Formulations (India) Ltd.?+

Promoter and group-holding details for Syncom Formulations (India) Ltd. are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Syncom Formulations (India) Ltd.?+

Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of approximately ₹1348 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent